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HTLV-1 infection is characterized by viral latency in the
large majority of infected cells and by the absence of vire-
mia. These features are thought to be due to the transcrip-
tional repression of viral expression in vivo. Specific
protein 1 (Sp1) binds to more than 1000 different cellular
promoters and regulates the expression of numerous
genes involved in cell proliferation, apoptosis, and differ-
entiation. In silico analysis of the nucleotide sequence of
the HTLV-1 LTR revealed the presence of two new poten-
tial Sp1 binding sites within the R region. We demon-
strated that the Sp1 and Sp3 transcription factors bound
in vitro to these sites by EMSAs and supershift experi-
ments. We also performed competition assays with a
probe corresponding to a Sp1 binding site consensus in
order to compare Sp1 binding affinity for the four pre-
viously reported and the two newly identified Sp1-binding
sites located in the HTLV-1 promoter. Point mutations of
the known and newly identified Sp1 sites were introduced
in the HTLV-I LTR cloned in either the sense or the anti-
sense orientation in the context of an episomal reporter
vector. We demonstrated that the Sp1 sites interfered with
both the sense transcription from the 5’LTR and the anti-
sense transcription from the 3’LTR (necessary for HBZ
expression in vivo). ChIP experiments to evaluate in vivo
Sp1 binding to the HTLV-I LTR U3 region are currently
under investigation. Our results demonstrate the presence
of two new functional Sp1 binding sites located in the
R region of the HTLV-I LTR.
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